Found 2 articles for: "interleukin seventeen"
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis
August 2026 | Volume 25 | Issue 8 | Original Article | 695 | Copyright © August 2026
Background: People with psoriasis are at increased risk for nonmelanoma skin cancers (NMSC) and melanoma. Conventional immunosuppressants and TNF-α inhibitors may further i...
Read MoreImproved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study
August 2026 | Volume 25 | Issue 8 | Original Article | 726 | Copyright © August 2026
Background: Sleep disorders are an underappreciated component of psoriasis-related morbidity. Biologic therapies targeting IL-17 and IL-23 may improve sleep quality by reducing s...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.